01.12.2017 | Research article | Ausgabe 1/2017 Open Access

Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa
- Zeitschrift:
- BMC Cancer > Ausgabe 1/2017
Background
Methods
Overall design
Study population
Measurements
KS
Updating vital status among the LTFU
Other measurements
Statistical analysis
Results
Identification and characteristics of the population of patients who were LTFU
AMPATH - Kenya
|
ISS - Uganda
|
Lighthouse- Malawi
|
UATH & NHA - Nigeria
|
Overall
|
|
---|---|---|---|---|---|
Patients diagnosed with Kaposi sarcoma
|
678
|
173
|
314
|
57
|
1222
|
Presumed LTFU in EMR (D1 in Fig.
1)
|
249
|
80
|
75
|
36
|
440
|
Reclassification after manual review of LTFU in EMR
|
|||||
Not truly LTFU: Vital status determined via manual review (N1b in Fig.
1)
|
16
|
1
|
1
|
0
|
18
|
Truly LTFU but vital status determined by repeat later review of records (N1a in Fig.
1)
|
11
|
0
|
2
|
11
|
24
|
Truly LTFU: Vital status missing after review of all records (D2 in Fig.
1)
|
222
|
79
|
72
|
25
|
398
|
Disposition of those who appear LTFU in EMR (D1 in Fig.
1)
|
|||||
Vital status updated by manual records review
|
27/249 (11%)
|
1/80 (1.3%)
|
3/75 (4.0%)
|
11/36 (31%)
|
42/440 (9.6%)
|
Vital status updated by phone contact alone
|
83/249 (33%)
|
10/80 (13%)
|
3/75 (4.0%)
|
15/36 (42%)
|
111/440 (25%)
|
Vital status updated by physical tracking
|
124/249 (50%)
|
47/80 (59%)
|
22/75 (29%)
|
3/36 (8.3%)
|
196/440 (45%)
|
Vital status not updated: consent available
|
15/249 (6.0%)
|
22/80 (28%)
|
37/75 (49%)
|
7/36 (19%)
|
81/440 (18%)
|
Vital status not updated: consent not available
|
0/249 (0%)
|
0/80 (0%)
|
10/75 (13%)
|
0/36 (0%)
|
10/440 (2.3%)
|
Disposition of those who were truly LTFU (N1a + D2 in Fig.
1)
|
|||||
Vital status updated by manual records review
|
11/233 (4.7%)
|
0/79 (0%)
|
2/74 (2.7%)
|
11/36 (31%)
|
24/422 (5.7%)
|
Vital status updated by phone contact alone
|
83/233 (36%)
|
10/79 (13%)
|
3/74 (4.1%)
|
15/36 (42%)
|
111/422 (26%)
|
Vital status updated by physical tracking
|
124/233 (53%)
|
47/79 (59%)
|
22/74 (30%)
|
3/36 (8.3%)
|
196/422 (46%)
|
Vital status not updated: consent available
|
15/233 (6.4%)
|
22/79 (28%)
|
37/74 (50%)
|
7/36 (19%)
|
81/422 (19%)
|
Vital status not updated: consent not available
|
0/233 (0%)
|
0/79 (0%)
|
10/74 (14%)
|
0/36 (0%)
|
10/422 (2.4%)
|
Disposition of those truly LTFU not found by manual records review (D2 in Fig.
1)
|
|||||
Vital status updated by phone contact alone
|
83/222 (37%)
|
10/79 (13%)
|
3/72 (4.2%)
|
15/25 (60%)
|
111/398 (28%)
|
Vital status updated by physical tracking
|
124/222 (56%)
|
47/79 (59%)
|
22/72 (31%)
|
3/25 (12%)
|
196/398 (49%)
|
Vital status not updated: consent available
|
15/222 (6.8%)
|
22/79 (28%)
|
37/72 (51%)
|
7/25 (28%)
|
81/398 (20%)
|
Vital status not updated: consent not available
|
0/222 (0%)
|
0/79 (0%)
|
10/72 (14%)
|
0/25 (0%)
|
10/398 (2.5%)
|
Disposition of those truly LTFU who were physically sought after in the community (D3 in Fig.
1)
|
|||||
Vital status updated by physical tracking
|
124/131 (95%)
|
47/69 (68%)
|
22/35 (63%)
|
3/8 (38%)
|
196/243 (81%)
|
Vital status not updated
|
7/131 (5.3%)
|
22/69 (32%)
|
13/35 (37%)
|
5/8 (63%)
|
47/243 (19%)
|
Success of tracking using combination of methods among those who consented and had sufficient information for tracking
|
|||||
Records, phone contact & physical tracking
a
|
218/225 (97%)
|
57/79 (72%)
|
27/40 (68%)
|
29/34 (85%)
|
331/378 (88%)
|
Phone contact & physical tracking
b
|
207/214 (97%)
|
57/79 (72%)
|
25/38 (66%)
|
18/23 (78%)
|
307/354 (87%)
|
AMPATH - Kenya
N = 233
|
ISS - Uganda
N = 79
|
Lighthouse - Malawi
N = 74
|
UATH & NHA - Nigeria
N = 36
|
Overall
N = 422
|
|
---|---|---|---|---|---|
Age at last visit, years
a
|
35 (30–42)
b
|
32 (29–40)
|
34 (29–40)
|
36 (32–42)
|
35 (29–41)
|
Male sex
a
|
62%
|
68%
|
78%
|
51%
|
65%
|
ART in use at last visit
|
82%
|
77%
|
47%
|
58%
|
73%
|
CD4+
T-cells
/mm
3
at last visit
c
|
126 (39–287)
|
183 (110–317)
|
231 (141–387)
|
259 (177–308)
|
159 (60–312)
|
CD4+
T-cells
/mm
3
at last visit
c
, category
|
|||||
0–50
|
28%
|
17%
|
6.7%
|
7.7%
|
22%
|
51–100
|
15%
|
4.4%
|
6.7%
|
7.7%
|
12%
|
101–200
|
23%
|
30%
|
27%
|
23%
|
24%
|
201–350
|
18%
|
30%
|
33%
|
46%
|
24%
|
351–500
|
9.4%
|
13%
|
20%
|
0%
|
10%
|
> 500
|
7.3%
|
4.4%
|
6.7%
|
15%
|
7.5%
|
Duration since KS diagnosis at last visit, months
|
0.96 (0–3.5)
|
1.9 (0.3–4.7)
|
1.9 (0–8.3)
|
4.7 (0.6–18.1)
|
1.4 (0.03–5.1)
|
Duration of being lost at database closure, months
|
17 (11–22)
|
30 (19–39)
|
31 (17–47)
|
26 (14–46)
|
21 (13–30)
|
Feasibility of searching for patients truly LTFU
Determinants of successful tracking by telephone and physical tracking
Unadjusted
|
Adjusted
a
|
|||
---|---|---|---|---|
Risk Ratio (95% CI)
|
P value
|
Risk Ratio (95% CI)
|
P value
|
|
Age at last visit, per 1 year increase
|
0.98 (0.95–1.01)
|
0.21
|
1.0 (0.97–1.03)
|
0.87
|
Sex
|
||||
Women
|
Ref.
|
Ref.
|
||
Men
|
0.72 (0.42–1.23)
|
0.23
|
0. 59 (0.35–1.01)
|
0.055
|
Duration of being lost at database closure, per 1 month increase
|
1.03 (1.02–1.05)
|
<0.001
|
0.99 (0.98–1.01)
|
0.48
|
Duration since KS diagnosis at last visit, per 1 month increase
|
0.96 (0.90–1.02)
|
0.19
|
0.94 (0.89–1.00)
|
0.065
|
ART in use at last visit
|
||||
Not on ART
|
Ref.
|
Ref.
|
||
On ART
|
0.40 (0.24–0.68)
|
0.001
|
0.68 (0.40–1.14)
|
0.144
|
Site
|
||||
AMPATH-Kenya
|
Ref.
|
Ref.
|
||
ISS-Mbarara
|
8.5 (3.8–19.1)
|
<0.001
|
9.7 (4.2–22.2)
|
<0.001
|
Lighthouse-Malawi
|
10.5 (4.5–24.5)
|
<0.001
|
12.1 (4.9–29.9)
|
<0.001
|
UATH & NHA-Nigeria
|
6.6 (2.3–19.3)
|
<0.001
|
8.7 (2.8–26.6)
|
<0.001
|